Monthly Archives: July 2024

CCV Capital’s Wei Zhou: AI Winter Coming in Second Half of Year, Remaining Genuine as Fake Ones Eliminated, Silicon Valley Startups Only Need to Survive to Next Cycle

SANTA CLARA, Calif., July 10, 2024 — “It’s very popular for Silicon Valley startups nowadays to say they only need to survive until the next cycle,” said Wei Zhou, who witnessed multiple cycles in venture capital industry, from his time at KPCB to now as Founding Managing Partner of CCV Capital.

This year, the primary market remains bleak, many VCs are facing the fundamental problem of capital shortage. However, Wei emphasized that in the entire VC investment field, AI is undoubtedly the direction where all investment institutions have invested the most and largest amounts this year, both in terms of number of deals and dollar amount.

In addition to “hot” this year, many “pseudo-entrepreneurs” and “pseudo-demands” have also emerged. Having witnessed the ups and downs of cutting-edge technology venture capital industry over the years, Wei realized: the AI winter is imminent.

“I predict that AI will cool down starting from the third quarter of the second half of this year, and remain cold until the second half of next year.”

Wei recalled the now classic case of Shukun Technology. The years 2015-2017 were when AI medical imaging applications in China were at their hottest. Many companies received huge financing. However, after 2017 the enthusiasm cooled sharply. Due to the previously overvalued AI imaging companies unable to generate revenue, the primary market remained cold from 2017 until early 2019.

“Nothing can grow in the winter cold, but it will also retain some particularly robust seedlings. So when winter passes, these few remaining seedlings will grow very fast. The business environment has also improved, the products are more mature, and meanwhile the competition has reduced.” 

Always daring to invest in cold sectors, Wei seized the timing in 2018 when AI medical imaging was at its coldest, and led Shukun Technology’s US$200 million Series A+ round. At that time, he judged that China’s AI medical imaging industry was ready, the technology was mature enough, and commercialization was the only thing lacking.

As represented by Shukun Technology, after 2019, the business environment and real application scenarios of AI imaging companies began to emerge. Sure enough, a number of companies that survived the winter saw their revenues rise.

The once wildly popular metaverse concept also basically fits this cyclic curve.

“It was hot for a year and a half before cooling, and still hasn’t warmed up,” he predicts that AI will follow the same pattern to cool for a year or year and a half. “So we’re not worried about AI. It’s very popular nowadays in Silicon Valley for startups to say they only need to survive until the next cycle.”

In Wei’s words, although everyone knew from the beginning that AI was a great direction, exactly where and how to land commercial applications was still unclear to all.

This reminds him of 2000 when everyone was investing in the Internet. Looking back, everyone now certainly knows the best entrepreneurial direction at that time was portal sites. But if you went into e-commerce and other sectors that rose later at that time, because the overall environment did not match and the market was not yet ready, it actually could not take off.

Wei bluntly said, AI entrepreneurs today also face the problem of timing. 

“Choosing what to do at this point in time is most appropriate. You may have great vision, but if you’re too early and the surrounding environment is not ready, that can be terrifying.”

In Wei’s view, AI is still just at the beginning application stage, and too many people are trying in different directions, but over the past year and a half, the overall AI environment has gradually shown some of the industry disorders of the cryptocurrency field back then.

“It became too hot, and many of those who rushed in were not thinking about how to use AI to solve actual existing problems, but were using various concepts to speculate. We call these pseudo-entrepreneurs, people chasing waves.”

From March last year to February this year when Sora came out, AIGC instantly became a star that sparked public enthusiasm around the tech arena.

Text-to-image, text-to-video, image-to-video, seem to have become buzzwords in the AI circle. 

Wei bluntly said, “Some money was invested in places where it was wasted.”

The current AIGC direction is like Internet startups back then. Take online stores for example, anyone who understands the basics of the Internet can participate. 

“Hard to say if you can win, but you can play in it.”

In his opinion, the current entrepreneurial environment in the AIGC field is similar.

“Basically, if you understand AI, just like Internet startups back then, as long as you notice some market demand, you can dive in to do it. You can enter just with your so-called ordinary business sense.”

He emphasized that generative AI technology is crucial, but “without differentiated technology far surpassing others, achieving technological monopoly, it will eventually become a so-called mass consumer product – every site will have it, everyone uses different vendors, the products won’t differ too much.” If this continues, companies with high value will be very few, “there will be a large batch of barely surviving companies.”

Under such circumstances, Wei believes it will be great if AI cools down in the second half of this year. “It will eliminate some so-called pseudo-entrepreneurs and pseudo-demands, making the environment cleaner. Some very solid entrepreneurs who are using technology to solve real problems will succeed.” 

Specifically, he believes that B2B applications that can influence industry cost structures and entire industry workflows are truly valuable AI applications. “For B2B, if your understanding of the industry is superficial, you can’t even get your foot in the door.” He analogized such applications to the “shield machines” used to build highways. 

But B2B applications also have higher requirements for founding teams.

Not only must they have sufficient understanding of the AI industry and progress, they also need to know the roles of each participant in the workflow, and be able to combine their own AI products with the entire workflow to produce a “shortcut effect”.

“They can sensitively feel which part of the costs the AI application can chop out of the workflow – not reducing, but making the participating side that previously took a big piece of the pie disappear, then your value is huge.”

In the interview, Wei mentioned Huski.ai, a Silicon Valley B2B startup he invested in. Huski.ai mainly provides cost-effective solutions for IP lawyers and their staff to help them review, monitor and enforce trademarks for clients.

Wei said law firms previously handled at most 10 cases a year, because the economic and manpower costs of evidence collection for law firms and brands to deter counterfeiters were very high. After Huski.ai intervened with AI, evidence collection costs were infinitely reduced, even directly replacing the evidence collection process, no longer subject to manpower constraints.

For entrepreneurs, Wei introduced three advantages of B2B entrepreneurial directions to Sohu Science and Technology. First, there are currently fewer teams with cross-border capabilities, so competition is relatively less fierce. Second, revenue comes relatively fast. Third, it can cause thorough changes to an industry.

Therefore, Wei frankly said that after investing in large model and platform companies, he now prefers “companies that cut very deep into a vertical field”.

Chinese AI companies cannot afford to expand globally only after becoming big, otherwise they will be “rolled to death” domestically, Wei said.

Although from the perspective of the AI field, he currently believes it has not reached the point of “unable to survive without going global”. But he emphasized, “Competition among Chinese companies domestically is extremely fierce, like the dark forest in The Three Body Problem. In the age of deglobalization, Chinese companies must still adhere to globalization.” 

“From day one, Chinese AI companies must consider and prepare in advance. Not like before, first growing big domestically then expanding globally. By then you will encounter a lot of obstacles and guard mentality. That is to say, from day one, as long as you have sufficient confidence and resources, begin implementation in parallel.”

For entrepreneurs, he advised focusing on future global target markets early on in the initial stages, establishing localized teams from partners to services with a “local image” in the home countries. 

“But you actually have close ties with Chinese companies and supply chains.” That is to say, while fully integrating with local markets, culture, regulations and so on to build a localized image, also maintain connections with China in resources, talent, supply chain and technology to form a distributed structure. “Becoming like many mushrooms sprouting simultaneously from different places, but with a certain degree of mutual support between them.”

Wei emphasized looking for investments to support Chinese innovation when making investment decisions. “In the past, 15-20% of our projects were overseas, certainly mostly related to China, either the founders were Chinese, or linking closely with China’s supply chain and market or talent.”

Wei pointed out that if a company can obtain sufficiently unique data in a vertical field to train models, it can create barriers. Take Shukun Technology as an example. After years of R&D and exploration, Subtle Medical used its unique medical data to self-research and train the multimodal medical model ShuKunGPT. 

In addition, if you can understand and grasp an industry deeply enough, you can also form leading advantages and barriers. In such vertical scenarios, “others can hardly catch up with you overnight, even if you have a lot of money, this is still an advantage.”

In summary, have to focus on subdivided industries. Once relatively unique vertical opportunities are identified, quickly build closed data loops. 

“In any event, I feel like under today’s environment, if entrepreneurs want to avoid the situation of ‘nothing grows under huge trees’, they still have to think clearly – exactly what is the direction and advantage of my startup.”

SOURCE CCV Capital


DAS LITAUISCHE DROHNEN-STARTUP GRANTA AUTONOMY STARTET MIT EINER 1-MILLIONEN-EURO-STARTKAPITALRUNDE DURCH

Die kampferprobte Überwachungstechnologie des Unternehmens wird die Art und Weise, wie Streitkräfte komplizierte und multidisziplinäre Aufklärungsmissionen bewältigen, verändern

VILNIUS, Litauen, 10. Juli 2024 — Granta Autonomy, ein innovatives Startup-Unternehmen, das sich auf vollautonome UAVs für Nachrichten-, Überwachungs- und Aufklärungsmissionen spezialisiert hat, gab heute den erfolgreichen Abschluss seiner Seed-Finanzierungsrunde in Höhe von 1 Million Euro bekannt. ScaleWolf VC, der führende litauische VC-Fonds und Accelerator für Technologien mit doppeltem Verwendungszweck, leitete die Runde mit Beteiligung von Brolis Defence und HFL Holdings. Das neue Kapital wird Granta Autonomy in die Lage versetzen, die Entwicklung und Produktion seiner hochmodernen leichten Überwachungs- und Aufklärungsdrohnen, Mikrokardans und digitalen Datalink-Software zu beschleunigen, die das Team persönlich an der ukrainischen Front getestet hat.

Granta Autonomy entwickelt seit 2015 ferngesteuerte Aufklärungsdrohnen, leichte Gimbals und die einzigartige Datalink-Software. Das von den ehemaligen Militäringenieuren Gediminas Guoba und Laurynas Litvinas gegründete Unternehmen beliefert heute die NATO-Streitkräfte in ganz Europa mit seiner Palette handgestützter Hornet-Drohnen und bietet darüber hinaus einer Reihe von Partnern seine firmeneigenen, äußerst zuverlässigen und leichten Mikrokardanringe an, die die leichtesten direkt angetriebenen Kardanringe auf dem Markt sind. Die Micro Gimbals von Granta Autonomy sind mit einem leistungsstarken Kamerasystem ausgestattet, das eine klare Bildaufnahme bei Tag über große Entfernungen (bis zu 5 km) ermöglicht und eine wichtige thermische Sicht für Nachteinsätze bietet, um den Erfolg der Missionen rund um die Uhr sicherzustellen.

„Die traditionelle Kampfzone entwickelt sich weiter, und die westlichen Armeen benötigen robuste, zuverlässige und flexible Lösungen. Granta Autonomy ist bestrebt, sicherzustellen, dass unsere Systeme in Europa hergestellt werden können, um die Abhängigkeit von externen Quellen zu verringern. Die heutige Finanzierung ermöglicht es uns, unsere Produktionskapazitäten zu erhöhen, um die in Europa benötigten Großanwendungen bereitzustellen”, sagte Gediminas Guoba, Gründer und Geschäftsführer von Granta Autonomy. „Unser Team arbeitet direkt mit den Soldaten in der Kampfzone zusammen, testet unsere Produkte und Software in Kampfgebieten und arbeitet gemeinsam an Lösungen, die sich auch unter schwierigsten Bedingungen bewähren. Diese von unseren westlichen Partnern geschätzte Erfahrung in der Kampfzone ist die Grundlage für unsere Mission, die Drohnenaufklärung für die Streitkräfte weltweit zu revolutionieren.”

Die neueste Drohne von Granta Autonomy, die Hornet XR, ist eine kleine, schwer zu entdeckende, von Hand zu startende Mini-Aufklärungsdrohne mit mehreren entscheidenden Merkmalen für verdeckte Missionen. Mit einem einfachen Wurfstart und einer geräuschlosen Flugdauer von bis zu 3 Stunden kann sie große Entfernungen (bis zu 160 km) unbemerkt zurücklegen. Vorprogrammierte Missionen gewährleisten einen autonomen Betrieb, selbst bei Funkstille oder in Umgebungen, in denen kein GNSS verfügbar ist. Das ultraleichte Flugzeug landet selbständig im Tiefstflugverfahren, sodass es auch auf engstem Raum leicht zu bergen ist, und sein kompaktes, modulares Design ermöglicht den bequemen Transport im Kofferraum eines Autos.

Die leistungsstarken, aber leichten GS-214X- und GS-218X-Mikrokardansysteme von Granta Autonomy ermöglichen es Hornets und anderen Drohnen von Drittanbietern, tagsüber scharfe Bilder aus großen Entfernungen (bis zu 5 km) aufzunehmen, und enthalten eine Wärmekamera für Einsätze bei Nacht. Die Digital Datalink Software von Granta Autonomy stellt sicher, dass der Gimbal mit den meisten Bodenkontrollstationen (GCS) kompatibel ist.

Guoba fügt hinzu: „Die Hornet XR ist ein Beispiel für unsere Konstruktionsphilosophie, die auf dem Fachwissen unserer militärischen UAV-Betreiber und -Ingenieure beruht. Sie bietet branchenweit führende Flugzeiten, einfache Bedienung und robuste Haltbarkeit, was zu größerer Effizienz, niedrigeren Kosten und unerreichter Zuverlässigkeit bei komplexen, multidisziplinären Missionen führt. Das Gleiche gilt für unsere Mikro-Kardanringe; als wir anfingen, gab es keine Kardanringe für kleine Drohnen wie die unseren auf dem Markt; jetzt produzieren wir die leichtesten direkt angetriebenen Kardanringe auf dem Markt.”

Edvinas Kerza, geschäftsführender Gesellschafter von ScaleWolf VC und ehemaliger Vizeminister des litauischen Verteidigungsministeriums, fügt hinzu: „Seit wir Gediminas und das Team kennengelernt haben, sind wir von der bahnbrechenden Technologie und der Vision des Granta Autonomy Teams beeindruckt. Ihr innovativer Ansatz zur Entwicklung von Überwachungs- und Aufklärungstechnologie ist unübertroffen und hat das Potenzial, die Art und Weise zu revolutionieren, wie Streitkräfte komplizierte und multidisziplinäre Aufklärungsmissionen bewältigen. Wir sind stolz darauf, ihre Mission in den kommenden Jahren mit autonomen UAVs in der Kampfzone zu unterstützen.”

Nachdem Russland im Februar 2022 in die Ukraine einmarschiert war, begann das in Vilnius ansässige Unternehmen Granta Autonomy mit der Lieferung seiner UAVs an die ukrainische Front. Heute betreibt die ukrainische Armee eine Batterie an UAVs von Granta Autonomy, die vom litauischen und anderen europäischen Verteidigungsministerien finanziert werden. Das Unternehmen stellt seine Technologie auch den NATO-Streitkräften in ganz Europa zur Verfügung.

Hinweise für Redaktionen:

Granta Autonomy ist ein innovatives und erfahrenes Ingenieurbüro mit Schwerpunkt auf der Entwicklung und Produktion von unbemannten Luftfahrtsystemen (UAS), Integrationen und Komponenten für Aufklärung, Überwachung, Zielerfassung und Aufklärung (ISTAR), Such- und Rettungsdienste sowie Streumunition.

Weitere Informationen finden Sie im Internet: https://www.grantaautonomy.com.

Medienkontakt: 
Nick Jones
[email protected]


Bessemer Venture Partners and IBM Ventures Invest in Rohirrim, Leader in RFP AI Automation

RESTON, Va., July 10, 2024 — Rohirrim, the leading Request for Proposal (RFP) AI automation platform, announced today that Bessemer Venture Partners and IBM Ventures made strategic investments in the company. These investments will further fuel Rohirrim’s mission to help businesses grow by streamlining and strengthening their RFP response strategy. Rohirrim’s RohanRFP platform unlocks the power of organizations’ data and uses its patented generative AI technology to help them create long-form, complex documents in a fraction of the time.

Since announcing its Series A round led by Insight Partners in 2023, the company has experienced rapid growth. Over the past 12 months, Rohirrim has seen a 400% growth in customers. One customer reported that the research that would normally take a team of SMEs 6 days to complete now takes 6 hours using RohanRFP. Additionally, Rohirrim was selected to participate in the Microsoft Pegasus Program, which offers additional support to startups to uncover leads, drive sales, and accelerate growth. Mike Papay, Cybersecurity and Risk titan, joined Rohirrim’s Board of Advisors as Chairman, and Dave O’Hara, former Microsoft CFO, was recently appointed to their Board of Directors.

“After countless nights of missing precious family moments to work on RFP responses, in 2021, I began working on a better way,” said Steven Aberle, Rohirrim CEO and Founder. “RohanRFP has delivered profound efficiencies to our customers, efficiencies that have the potential to be game changers for organizations. This is the core of who we are and what drives us every day as we execute our mission: to reimagine work and deliver higher win rates, increased volume, and revenue growth for all our customers.” 

“When we looked at companies in the RFP automation space, Rohirrim stood out as the clear market leader for commercial and public sector organizations that deal with lengthy and complex proposal creation processes and care about best-in-class data security. Rohirrim’s technology has the potential to provide meaningful business growth to organizations, and we believe they have the team, technology, and infrastructure in place to make it happen,” said Aia Sarycheva, Investor at Bessemer Partner Ventures.

By generating the first draft of an RFP in a fraction of the time, proposal teams can focus on what they do best: storytelling and persuasion – making their responses more compelling and competitive. RohanRFP can profoundly impact an organization’s ability to grow by reducing costs and increasing the volume of RFP submissions.

“As an AI native platform, Rohirrim is uniquely poised to deliver on early promises of generative AI while protecting an organization’s proprietary data – aligning to IBM’s vision for helping organizations harness the power of AI with safety and responsibility at the forefront. Rohirrim brings incredible efficiencies to proposal writing with AI content creation,” said Tom Whiteaker, Partner at IBM Ventures.

In addition to being investors in the company, the IBM team experienced firsthand the power of the RohanRFP platform as early adopters. They immediately saw the efficiency gains and impact on their organization. IBM Ventures Partner Tom Whiteaker will join as a board observer alongside Bessemer Venture Partners’ Mike Droesh and Aia Sarycheva.

About Bessemer Venture Partners

Bessemer Venture Partners helps entrepreneurs lay strong foundations to build and forge long-standing companies. With more than 145 IPOs and 300 portfolio companies in the enterprise, consumer and healthcare spaces, Bessemer supports founders and CEOs from their early days through every stage of growth. Bessemer’s global portfolio has included Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr, and Toast and has more than $18 billion of assets under management. Bessemer has teams of investors and partners located in Tel Aviv, Silicon Valley, San Francisco, New York, London, Hong Kong, Boston, and Bangalore. Born from innovations in steel more than a century ago, Bessemer’s storied history has afforded its partners the opportunity to celebrate and scrutinize its best investment decisions (see Memos) and also learn from its mistakes (see Anti-Portfolio).

About Rohirrim

Rohirrim uses its patented, first-ever, organization-specific generative-AI technology to develop groundbreaking products that aim to reimagine how people work, particularly when it comes to time-intensive, repetitive, and manual tasks. Rohirrim was born out of the need to improve the work-life balance of proposal teams and has stayed true to its vision in the continuous pursuit of new ways to make people’s work lives better. Learn more at www.rohirrim.ai

Media Contact:
Farah van Caloen
[email protected]

SOURCE Rohirrim


MeetRecord Accoladed by G2 for Excellence in Sales Coaching and Customer Experience

SAN FRANCISCO, July 10, 2024 — MeetRecord, a Revenue Automation platform that specializes in sales coaching, has bagged several awards from G2. Known for its ability to capture key insights from every sales conversation and support informed decision-making, MeetRecord received over 8 badges in 4 different categories, showcasing its excellence in sales coaching and customer experience.

Key awards include badges for “Ease of Doing Business, Ease of Admin, and High Performer.” These badges highlight MeetRecord’s easy-to-use and effective solutions, which help businesses boost their sales performance and simplify administrative tasks.

MeetRecord’s sales coaching tools help sales teams perform better by using advanced analytics and easy-to-understand reports. These features allow sales leaders to find strengths and areas for improvement, promoting continuous growth and success.

Customer experience is a major focus for MeetRecord. This dedication is reflected in the High Performer badge from G2, which shows the company’s ability to provide top-quality services that meet clients’ changing needs. The Ease of Doing Business badge emphasizes how simple it is to integrate MeetRecord into existing workflows, enhancing productivity and ROI.

“Our goal has always been to provide great value to our customers through innovative solutions and outstanding service,” said Paras Jain, Co-founder & CCO, of MeetRecord. “By focusing on our customers’ success, we create strong, beneficial relationships. The recent G2 awards, including Ease of Doing Business, Ease of Admin, and High Performer, prove our commitment to excellence and customer satisfaction.”

MeetRecord’s platform supports sales teams with real-time feedback and actionable insights, helping them refine their strategies and achieve their targets. The G2 badges, especially High Performer and Ease of Doing Business, highlight MeetRecord’s success in delivering these benefits.

As MeetRecord continues to grow and innovate, the company remains dedicated to providing top-notch solutions that meet clients’ evolving needs. The recent G2 recognitions inspire MeetRecord to keep pushing the limits of sales intelligence and customer experience.

For more information about MeetRecord, visit – https://www.meetrecord.com

About MeetRecord

MeetRecord‘s Revenue Automation Solution empowers Sales teams with streamlined deal flow, intuitive pipeline visualization, and personalized AI Sales coaching. It enhances sales collaboration, accelerates deal conversion, offers visibility into conversations, and provides comprehensive deal summaries, ensuring peak performance. Trusted by industry leaders like Gymlaunch, Jisr, Fyle, Kisi and many more.

SOURCE MeetRecord Inc.


Volumez Announces Completion of $40 Million Series A Funding to Revolutionize Cloud-Aware Data Infrastructure

The company’s innovative controller-less orchestration software harnesses the power of Linux to quickly execute modern data infrastructure for data-intensive workloads using a declarative interface that makes it easy to deploy a wide variety of applications in hybrid and multi-cloud environments. Volumez will use the funds to continue to expand its customer base and grow its business operations in the U.S. and EMEA while maintaining R&D execution in Israel.

“This round of funding is a strong commitment of our existing and new strategic investors to support our business growth plans, the partnerships with the major cloud providers (Amazon Web Services, Microsoft Azure, and Oracle Cloud), and our additional customers,” said Amir Faintuch, CEO of Volumez. “This funding will enable us to broaden our cloud services to additional AI and machine learning workloads, expanding our solution offerings on the Volumez platform.”

“Cloud is the new frontier for storage revolution, and we are betting on Volumez to lead the way as the pioneer of composable data infrastructure for the cloud,” said Samsung Ventures representative. “No other vendor is delivering ultra-fast, guaranteed performance at significant cost savings in the form of “data infrastructure as code” that automates storage management to reduce risks, control cloud costs, and accelerate application deployment.”

“We are excited to continue our support for Volumez as they accelerate their customer growth and strategic product development,” said Byron Knight, President at KDT. “KDT is committed to empowering visionary entrepreneurs who are building transformative companies and revolutionizing industries. Volumez exemplifies this by unlocking the potential of its unique cloud-aware architecture in the data infrastructure domain, driving innovation, and setting new benchmarks for enterprise software and technological advancement.”

About Volumez 

Volumez is a revolutionary composable data infrastructure company businesses employ to realize the true potential of their data. With its innovative controller-less architecture, Volumez tackles latency and scalability challenges by establishing direct Linux data paths, ensuring exceptional performance and resiliency. Driven by cutting-edge technology and a customer-centric approach, Volumez offers comprehensive solutions that streamline data workflows, enhance data quality, and drive informed decision-making.

Discover more at volumez.com.

Photo – https://mma.prnewswire.com/media/2458123/Volumez_Series_A.jpg

SOURCE Volumez


Granza Bio Raises $7M+ Seed Funding to Advance the Delivery of Cancer Treatment and Genetic Medicines

SAN FRANCISCO, July 10, 2024 — Therapeutic delivery platform Granza Bio announced today the close of its oversubscribed $7.14M Seed led by Felicis and Refactor, along with Y Combinator and notable angel investors.

Founded in 2024 by a team of cancer and immunology researchers at the University of Oxford, Granza Bio utilizes the discovery of “attack particles,” a powerful suite of weapons in the immune system’s arsenal that can fight diseases such as cancers, autoimmunity and infections.

“With attack particles, we discovered a new feature of the immune system that has the potential to transform the therapeutic landscape. They offer the power of cellular therapies with the off-the-shelf ease of antibody-based drugs,” said Granza Bio co-founder Michael Dustin, Professor of Molecular Immunology at Oxford.

However, the team realized they lacked an effective delivery system for packaging and delivering attack particles to specific tissues.

To solve this problem, Granza Bio’s platform offers a unique delivery system that focuses on three key areas:

1) The ability to deliver a variety of cargo types (such as RNAs, proteins, and attack particles)
2) The ability to deliver to a range of tissue sites
3) Overcoming immunological activation triggered by the delivery vehicle

“We are developing a series of precision delivery shells that can encompass and direct any therapeutic cargo to the correct destination in our body. This work will be fundamental for turning promising discoveries in genetic medicine and cancer therapeutics into impactful treatments for patients,” said Granza co-founder and Chief Executive Officer, Dr. Ashwin Nandakumar.

“Through the development of a comprehensive library of engineered shells, we aim to tackle the challenges of tropism, immunogenicity, and stability head-on. Our strength lies in the interdisciplinary nature of our team, spanning fundamental immunology to industrial manufacturing and scale-up processes. This is a pivotal moment for the field of drug delivery therapeutics and we are at the forefront of this transformation,” said Dr. Ashwin Jainarayanan, Granza Bio’s Chief Scientific Officer.

Dr. Nandakumar, CEO, holds a PhD in Oncology, has previously set up clinical trials, and brings oncology start-up experience. Dr. Jainarayanan, CSO, is a PhD in Interdisciplinary Bioscience and was recently selected as a Schmidt Science Fellow. Prof. Dustin is also the director of research at the Kennedy Institute of Rheumatology at Oxford.

“The immune system is nature’s most powerful mechanism for biological remediation. By improving the delivery and specificity of naturally occurring attack particles, Granza Bio can unlock a new world of capabilities for oncological and immunological diseases,” said Tobi Coker, Deal Partner at Felicis. “Granza encompasses a unique combination of significant scientific advancements, a founding team with complementary skills, and deep domain expertise. We are thrilled to be working with them.”

“I focus on finding technical founders who are experts in their fields and are magnets for customers, talent, and investors. Both Ashwins really fit that perfectly, in my opinion, as they build a better delivery mechanism for a variety of therapeutics,” said Zal Bilimoria, founding partner at Refactor.

The investment round also includes participation from other investors including Metaplanet, Zeno Ventures, Ritual Capital, Pioneer Fund, Oxford Angel Fund, and North South Ventures. Notable angels joined the round including Richard Aberman (former YC Visiting Group Partner), JJ Fliegelman (former YC Visiting Group Partner), Eric Migicovsky (former YC Group Partner), Eric Eldon (former editor of TechCrunch), Eli Brown (founder, Guilded), Eoghan Mccabe (founder, Intercom), Benjamin Bryant (co-founder, Earbits), Yotam Rosenbaum (co-founder, Earbits), Will Olsen (co-founder, Engage Bio) and Joel Meyer.

For partnership and licensing opportunities, please reach out to [email protected].
Learn more at granzabio.com.

About Granza Bio 
Founded in 2024, Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues. For their lead candidate, Granza Bio is leveraging the discovery of the immune system’s powerful suite of weapons, “attack particles”. Utilizing their advanced delivery platform, they aim to target these “attack particles” against a range of diseases such as cancer, autoimmune disorders, and infections. The company has recently raised a $7M+ Seed round led by Felicis and Refactor, along with Y Combinator and notable ventures and angel investors. Granza Bio was co-founded by Dr. Ashwin Nandakumar, Dr. Ashwin Jainarayanan, and Prof. Michael Dustin, researchers from the University of Oxford. Learn more at granzabio.com. Visit our linkedin.  

SOURCE Granza Bio Corporation


AIRS Medical Secures $20M in Series C Funding to Advance AI-Powered Preventive Healthcare Solutions

SEOUL, South Korea, July 10, 2024 — AIRS Medical, a pioneering force in artificial intelligence (AI) and robotics for healthcare applications, today announced the completion of its Series C funding round, securing $20 million from seven institutional investors in Korea. The investment, led by BSK Investment and Shinyoung Securities, underscores confidence not only in the company’s flagship product, SwiftMR™, but also in its larger mission to revolutionize preventive healthcare through technology innovation.

Transforming MRI

SwiftMR™ uses deep learning technology to enhance magnetic resonance imaging (MRI) scan speeds by as much as 50% compared to the standard of care.* On average, radiology centers and hospitals that integrate SwiftMR™ achieve a 38% increase in patient throughput and a 22% reduction in business hours, leading to $44,000 per month in additional revenue and an $8,000 reduction in monthly operating costs.

SwiftMR™ is a scan time reduction solution with whole pulse-sequence coverage and true super resolution. This cutting-edge technology has set the standard in diagnostic imaging, helping to address critical roadblocks radiology centers and hospitals face, such as long patient wait times and the downstream effects of delayed diagnoses.

Improving patient outcomes

A frequent problem in healthcare is the delayed diagnosis of patients, often after symptoms have advanced. This, along with resource shortages, results in worse outcomes.

AIRS Medical is paving the way to detect diseases proactively, before they manifest. Through AI and robotics, AIRS Medical is democratizing the best diagnostics and prognostics, reducing costs and increasing the accessibility of MRI scans. Ultimately, this empowers patients with conditions such as dementia, stroke, and cancer to receive early diagnoses and improve their chances of better health.

Expanding access to care

In its quest to deliver the highest-quality preventive care to all, AIRS Medical is rapidly expanding. Backed by a talented team, SwiftMR™ was initially launched in Korea in 2021. By 2023, the technology had successfully entered the United States and Europe, markets that now account for over half of the company’s annual recurring revenue (ARR).

“We’re thrilled to receive this substantial support from our investors,” said Hyeseong Lee, CEO of AIRS Medical. “This funding will empower us to increase access to preventive healthcare services and create a healthier future for people around the globe.”

Building a better future

With this latest round of funding, AIRS Medical is poised to accelerate its growth and innovate beyond the award-winning SwiftMR™. The company plans to expand its presence in international markets, invest in research and development, and ultimately improve patient outcomes worldwide.

For more information about AIRS Medical, visit https://airsmed.com/en/.

*For investigational purposes in countries outside of the United States, South Korea, Canada, Brazil, Japan, Taiwan, Malaysia, Saudi Arabia, UAE, Thailand, Vietnam, and Indonesia. FDA 510(k)-cleared to support images with scan time reduction by up to 50% in the United States.

For press inquiries or questions about this release please contact:

Ashley Guidace
AIRS Medical
Director of Global Marketing
[email protected] 

SOURCE AIRS Medical


Backed by world class accelerators and investors, ThirdFi raised $2m in token investment, to scale and monetize web3 infrastructure with data for AI and developer tools

SINGAPORE, July 10, 2024ThirdFi.org, a web3 infrastructure protocol that empowers web3 users with identity and developers with api and sdk, has raised $2m in token financing investments from world class accelerators and pre-seed investors; Techstars, Chainlink, Outlier Ventures, Alphabit Capital and more.

This raises ThirdFi’s FDV to $20m after building in the bear market for the last 2 years. With its leadership and experienced team, ThirdFi is transforming to a modular web3 infrastructure protocol that focuses on AI applications on decentralized finance (DeFi).

Since its founding in 2022 and graduating from Techstars Web3 accelerator program, ThirdFi has been on the mission to empower developers and web3 startups with dev-toolings, API and sdk, building “picks and shovel”, to accelerate the adoption of DeFi to 1 billion users. In the last 2 years, ThirdFi has amassed more than 170,000 users with more than $46 million on mainnet and L2 transactions by partnering with more than 50 web3 communities and protocols.

With the v2 launch that targets web3 users data to empower AI builders, ThirdFi is poised to grow in the upcoming blockchain AI market that is expected to grow to $2.7 billion by 2031 at a 25% CAGR yearly. The v2 creates even a better product-market fit to capture the growth of developers and users in AI applications such as AI agents, models and signals.

Users can now participate in the early access of Data-to-Earn campaign to gain data points for future airdrop allocations and contribute to the blockchain AI movement where users now own their identity and data points. These data points are NFT-bound and tradeable in the future making it a web3-centric approach and empowering users to own their data.

About ThirdFi.org
Website: https://www.thirdfi.org/
Twitter: https://x.com/thirdfiorg
Telegram: https://t.me/thirdfi_org

SOURCE ThirdFi


Miravast Completes Fundraise For Its Second Flagship Fund

NEW TOWN, Pa., July 10, 2024 — Miravast Asset Management LLC, a leading vertically integrated investment manager with deep experience underwriting longevity risk and investing in life settlements is pleased to share that it recently completed fundraising for Miravast ILS Credit Opportunities II LP (“Fund II”) with $346 million of fund commitments.  

“Closing Fund II represents an important milestone for Miravast. We continue to believe Miravast offers institutional investors an unparalleled team of medical underwriting and actuarial experts. The LP support we are fortunate to have for Fund II further exemplifies the confidence that the institutional LP community has in the Miravast team,” said Dave Beckelman, Chief Executive Officer. 

“As with its predecessor, Fund II has a global institutional investor base.  We are grateful to have support from existing and new institutional LP’s as we execute our strategy.  We have invested a portion of Fund II’s committed capital and will continue to leverage our in-house expertise as we pursue additional investments,” said Dave Cherkas, Executive Vice President.  

Schule Roth & Zabel LLP served as legal counsel for Miravast Asset Management and Fund II. 

About Miravast Asset Management LLC

Founded in 2012, Miravast (www.miravast.com) is a vertically integrated asset management firm with approximately $1.2 billion of assets under management. Miravast’s experience in life insurance product design and medical underwriting, coupled with our perspective on investment structures, allows us to help institutional investors navigate the complexities of investing in longevity risk, chiefly life settlements. 

Our in-house medical underwriters utilize a proprietary view based on a significant population of settled life insurance policies.  Additionally, our underwriting model provides interest alignment that differs from the outsourced volume-based models most often utilized by the broader market. Our underwriting and life insurance product experience can lead to significant differences in our view compared to the market’s view. We seek to identify opportunities that others miss and avoid those that others may overvalue while still acquiring assets at market value.  

Miravast team members have led the investment of approximately $6 billion since 2001. We advise separately managed accounts and pooled investment funds for pensions, endowments, insurance companies, and family offices. 

SOURCE Miravast LLC